Literature DB >> 12683249

Ocular surface reconstruction: limbal stem cell transplantation.

Joung Y Kim1, Ali R Djalilian, Gary S Schwartz, Edward J Holland.   

Abstract

In summary, the management of patients with severe ocular surface disease remains difficult. Significant progress has been made toward understanding limbal stem cell disease, and surgical treatments have been refined. Short- and long-term successes have been achieved and have improved the quality of life for patients who otherwise have had no other treatment options. Further research is needed to determine the factors leading to successful long-term stem cell transplantation and those factors associated with transplantation failure. Developments in the management of limbal stem cell disease are progressing rapidly, and the long-term outlook for patients with this challenging disease continues to improve.

Entities:  

Mesh:

Year:  2003        PMID: 12683249     DOI: 10.1016/s0896-1549(02)00107-4

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  13 in total

1.  Assessment of limbus and central cornea in patients with keratolimbal allograft transplantation using in vivo laser scanning confocal microscopy: an observational study.

Authors:  Jiaxu Hong; Tianyu Zheng; Jianjiang Xu; Sophie X Deng; Ling Chen; Xinghuai Sun; Qihua Le; Yimin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-26       Impact factor: 3.117

Review 2.  Strategies for reconstructing the limbal stem cell niche.

Authors:  Ghasem Yazdanpanah; Zeeshan Haq; Kai Kang; Sayena Jabbehdari; Mark L Rosenblatt; Ali R Djalilian
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

3.  Update on limbal stem cell transplantation.

Authors:  Pejman Bakhtiari; Ali Djalilian
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

Review 4.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

5.  Adverse effects of systemic immunosuppression in keratolimbal allograft.

Authors:  M Krakauer; J D Welder; H K Pandya; N Nassiri; A R Djalilian
Journal:  J Ophthalmol       Date:  2012-02-28       Impact factor: 1.909

6.  The use of an IL-1 receptor antagonist peptide to control inflammation in the treatment of corneal limbal epithelial stem cell deficiency.

Authors:  E Fok; S R Sandeman; A L Guildford; Y H Martin
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

7.  Donor-transmitted melanoma after limbal stem cell transplantation.

Authors:  Anas Alsara; Muhammad Rafi
Journal:  Avicenna J Med       Date:  2017 Apr-Jun

8.  Aniridia-related keratopathy: Structural changes in naïve and transplanted corneal buttons.

Authors:  André Vicente; Berit Byström; Mona Lindström; Ulf Stenevi; Fátima Pedrosa Domellöf
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

9.  Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the Clinical Outcome Assessment in Surgical Trials assessment tool.

Authors:  Alex J Shortt; Catey Bunce; Hannah J Levis; Peter Blows; Caroline J Doré; Amanda Vernon; Genevieve A Secker; Stephen J Tuft; Julie T Daniels
Journal:  Stem Cells Transl Med       Date:  2014-01-17       Impact factor: 6.940

Review 10.  The ocular surface chemical burns.

Authors:  Medi Eslani; Alireza Baradaran-Rafii; Asadolah Movahedan; Ali R Djalilian
Journal:  J Ophthalmol       Date:  2014-07-01       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.